...
首页> 外文期刊>Acta orthopaedica Scandinavica. >Monitoring referral and treatment in soft tissue sarcoma: study based on 1,851 patients from the Scandinavian Sarcoma Group Register.
【24h】

Monitoring referral and treatment in soft tissue sarcoma: study based on 1,851 patients from the Scandinavian Sarcoma Group Register.

机译:监测软组织肉瘤的转诊和治疗:基于来自斯堪的纳维亚肉瘤组登记册的1,851例患者的研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This report is based on 1.851 adult patients with soft tissue sarcoma (STS) of the extremities or trunk wall diagnosed between 1986 and 1997 and reported from all tertiary referral centers in Norway and Sweden. The median age at diagnosis was 65 years and the male-to-female ratio was 1.1:1. One third of the tumors were subcutaneous, one third deep, intramuscular and one third deep, extramuscular. The median size was 7 (1-35) cm and 75% were high grade (III-IV). Metastases at presentation were diagnosed in 8% of the patients. Two thirds of STS patients were referred before surgery and the referral practices have improved during the study. The preoperative morphologic diagnosis was made with fine-needle aspiration cytology in 81%, core-needle biopsy in 9% and incisional biopsy in 10%. The frequency of amputations has decreased from 15% in 198688 to 9% in 1995-1997. A wide surgical margin was achieved in 77% of subcutaneous and 60% of deep-seated lesions. Overall, 24% of operated STS patients had adjuvant radiotherapy. The use of such therapy at sarcoma centers increased from 20% 1986-88 to 30% in 1995-97. Follow-up has been reported in 96% of the patients. The cumulative local recurrence rate was 0.20 at 5 years and 0.24 at 10 years. The 5-year metastasis-free survival rate was 0.70.
机译:本报告基于1986年至1997年间诊断出的四肢或躯干壁软组织肉瘤(STS)的成年患者1.851名,并从挪威和瑞典的所有三级转诊中心报告。诊断时的中位年龄为65岁,男女之比为1.1:1。三分之一的肿瘤是皮下的,三分之一是肌内的,而三分之一则是肌外的。中位数为7(1-35)厘米,75%为高等级(III-IV)。 8%的患者被诊断出出现转移。三分之二的STS患者在手术前被转诊,并且在研究期间转诊实践得到了改善。术前形态学诊断为细针穿刺细胞学检查为81%,芯针活检为9%,切开活检为10%。截肢的频率从198688年的15%降低到1995-1997年的9%。 77%的皮下病变和60%的深部病变实现了广泛的手术切缘。总体而言,手术的STS患者中有24%接受了辅助放疗。在肉瘤中心使用这种疗法的比例从1986-88年的20%增加到1995-97年的30%。据报道有96%的患者进行了随访。累积局部复发率在5年时为0.20,在10年时为0.24。 5年无转移生存率为0.70。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号